It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

20

M/CLEAR

TOKYO (2 a.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Novavax

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan approves Novavax COVID-19 vaccine

National / Science & Health Apr 19, 2022

Japan approves Novavax COVID-19 vaccine

Distribution of Novavax vaccines to local governments are expected to start in late May, the health ministry said.

EU backs Novavax shot as region's fifth COVID-19 vaccine

World Dec 21, 2021

EU backs Novavax shot as region's fifth COVID-19 vaccine

It is not clear yet how Novavax performs against the omicron variant, or whether a booster dose will be needed.

Japan secures 150 million Novavax vaccine doses

National Sep 7, 2021

Japan secures 150 million Novavax vaccine doses

Known as TAK-019 in Japan, the vaccine has proved to be 90% effective in preventing infections at clinical trials held abroad.

A vaccine the world badly needs looks better than ever

Commentary / World Jun 19, 2021

A vaccine the world badly needs looks better than ever

by Max Nisen

The vaccine is also more stable and easily stored than mRNA vaccines, which will be helpful in broad distribution.

Novavax COVID-19 shot highly effective against variants in trial

World Jun 15, 2021

Novavax COVID-19 shot highly effective against variants in trial

by Todd Gillespie and Robert Langreth

The company plans to apply for regulatory clearance globally, with much of the first available doses going to low- and middle-income countries.

Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan

National / Science & Health Feb 24, 2021

Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan

The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.

COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says

World Jan 29, 2021

COVID-19 vaccine 89.3% effective in U.K. trial but less so in South Africa, Novavax says

The U.S. company believes the vaccine was 85.6% effective against the highly transmissible U.K. variant, which was also circulating during the study.

South Korea in talks to secure 40 million doses of Novavax vaccine

World / Science & Health Jan 20, 2021

South Korea in talks to secure 40 million doses of Novavax vaccine

South Korea is in talks to purchase 40 million doses of a coronavirus vaccine developed by Novavax, its local manufacturer SK Bioscience said Wednesday. The deal, if agreed, will boost supply of COVID-19 vaccines in the country to 146 million doses, more than enough for ...

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Biden vows to defend Taiwan as Kishida pledges unprecedented hike in defense spending
    Biden and Kishida shake hands as they attend a bilateral meeting at the State Guesthouse in Tokyo on Monday.
  • Seven arrive from U.S. for first test tours before Japan reopens to tourism
    People from the United States arrive for the first small-scale test tours in Japan since measures were imposed to control the spread of COVID-19, at Narita Airport near Tokyo on Tuesday.
  • Government clarity needed as Japan eyes border reopening for tourism
    Japan is believed to have lost ¥10.96 trillion in revenue in 2020 and more than ¥22 trillion since the pandemic began after closing its borders to tourists in response to COVID-19.
  • Japanese political parties agree on outline of bill to protect porn victims
    Major Japanese ruling and opposition parties have agreed on an outline of a planned bill to protect people who appear in pornographic videos against their will.
  • Biden launches Indo-Pacific Economic Framework with 13 nations including Japan
    U.S. President Joe Biden, Indian Prime Minister Narendra Modi and Prime Minister Fumio Kishida attend the Indo-Pacific Economic Framework for Prosperity launch event on Monday in Tokyo.
  • Is the next Shohei Ohtani already in NPB?

    Thumbnail image
  • Kill Japan's elderly? A film at Cannes probes a chilling idea.

    Thumbnail image
  • China's Gen Z has the power to make or break western brands

    Thumbnail image
  • North Korea launches apparent ICBM, a day after Biden departs Asia

    Thumbnail image
  • U.N. envoy faces pressure on China trip over new Xinjiang leak

    Thumbnail image

PODCAST

  • DEEP DIVE

    When will Japan open to tourists?

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times